BDTX$1.80+2.57%
Black Diamond Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$103.16M
Float & O/S:
Inst Own:
DilutionScan read 24 of Black Diamond Therapeutics, Inc.'s SEC filings and found 1 warrant series, 1 ATM program, 2 shelf registrations and 1 S-1 registration on file for BDTX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.